Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 

Publications

Showing records 1 - 20 (of 61)

Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)

ID Author Year Title Publisher
1194483  Chirgwin, Jacquie; Sun, Zhuoxin; Smith, Ian; Price, Karen N; Thürlimann, Beat; Ejlertsen, Bent; Bonnefoi, Hervé; Regan, Meredith M; Goldhirsch, Aron; Coates, Alan S; BIG 1-98 Collaborative and International Breast Cancer Study Groups 2012 The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause Breast cancer research and treatment
1194311  Bolla, Daniele; Wiedemann, Nicole; Ohlschlegel, Christin; Schöning, Andrea; Stickel, Juliane; Thürlimann, Beat; Hornung, René 2011 Pseudoangiomatous stromal hyperplasia of breast in man: a case report The breast journal
1194486  Swiss Grp Clinical Canc Res Sakk, 2011 Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer : a proof-of-concept trial (SAKK 23/03) Endocrine related cancer
1194793  Joerger, M; Thürlimann, B; Huober, J 2011 Small HER2-positive, node-negative breast cancer : who should receive systemic adjuvant treatment? Annals of oncology
1195706  Colleoni, Marco; Giobbie-Hurder, Anita; Regan, Meredith M; Thürlimann, Beat; Mouridsen, Henning; Mauriac, Louis; Forbes, John F; Paridaens, Robert; Láng, István; Smith, Ian; Chirgwin, Jacquie; Pienkowski, Tadeusz; Wardley, Andrew; Price, Karen N; Gelber, Richard D; Coates, Alan S; Goldhirsch, Aron 2011 Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study Journal of clinical oncology
1023019  Ess, S; Joerger, M; Frick, H; Probst-Hensch, N; Vlastos, G; Rageth, C; Lütolf, U; Savidan, A; Thürlimann, B 2011 Predictors of state-of-the-art management of early breast cancer in Switzerland Annals of oncology
1195013  Bernhard, Jürg 2011 Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial Breast cancer research and treatment
1194484  Viale, G; Regan, M M; Dell'Orto, P; Mastropasqua, M G; Maiorano, E; Rasmussen, B B; MacGrogan, G; Forbes, J F; Paridaens, R J; Colleoni, M; Láng, I; Thürlimann, B; Mouridsen, H; Mauriac, L; Gelber, R D; Price, K N; Goldhirsch, A; Gusterson, B A; Coates, A S; BIG 1-98 Collaborative and International Breast Cancer Study Groups 2011 Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial Annals of oncology
1196819  Regan, Meredith M; Neven, Patrick; Giobbie-Hurder, Anita; Goldhirsch, Aron; Ejlertsen, Bent; Mauriac, Louis; Forbes, John F; Smith, Ian; Láng, István; Wardley, Andrew; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Coates, Alan S; Thürlimann, Beat; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG) 2011 Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up The Lancet oncology
1196820  Regan, Meredith M; Price, Karen N; Giobbie-Hurder, Anita; Thürlimann, Beat; Gelber, Richard D; International Breast Cancer Study Group and BIG 1-98 Collaborative Group 2011 Interpreting Breast International Group (BIG) 1-98 : a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer Breast cancer research
1194485  Joerger, M; Templeton, A; Köberle, D; Engler, H; Riesen, W F; Thürlimann, B 2011 Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates Cancer chemotherapy and pharmacology
1193767  Huober, Jens; Baumann, Michael; Rochlitz, Christoph; Aebi, Stefan; Güth, Uwe; von Moos, Roger; Müller, Andreas; von Rohr, Lukas; Widmer, Isabelle; Thürlimann, Beat 2011 Trastuzumab treatment beyond progression in advanced breast cancer : patterns of care in six Swiss breast cancer centers Oncology
1196821  Joerger, M; Riesen, W F; Thürlimann, B 2011 Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer Journal of oncology pharmacy practice
1195973  Scientific Board; Harbeck, Nadia; von Minckwitz, Gunter; Thürlimann, Beat 2010 Bisphosphonates in adjuvant treatment of early breast cancer Critical reviews in oncology, hematology
1193391  Thurlimann, Beat 2010 [Commentary from the viewpoint of an advocate. "Breast cancer mortality in organized mammography screening in Denmark: a comparative Study"] Schweizerische Rundschau für Medizin PRAXIS
1194092  Paridaens, Robert J; Gelber, Shari; Cole, Bernard F; Gelber, Richard D; Thürlimann, Beat; Price, Karen N; Holmberg, Stig B; Crivellari, Diana; Coates, Alan S; Goldhirsch, Aron 2010 Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer Breast cancer research and treatment
1193392  Mouridsen, Henning T; Lønning, Per; Beckmann, Matthias W; Blackwell, Kimberly; Doughty, Julie; Gligorov, Joseph; Llombart-Cussac, Antonio; Robidoux, Andre; Thürlimann, Beat; Gnant, Michael 2010 Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer Expert review of anticancer therapy
1195422  Phillips, Kelly-Anne; Ribi, Karin; Sun, Zhuoxin; Stephens, Alisa; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg 2010 Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial The breast
1192697  von Moos, Roger; Caspar, Clemens B.; Steiner, Rolf; Angst, Rahel; Inauen, Roman; Schmieding, Kerstin; Thürlimann, Beat 2010 Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes Onkologie
1196510  Ess, S; Savidan, A; Frick, H; Rageth, Ch; Vlastos, G; Lütolf, U; Thürlimann, B 2010 Geographic variation in breast cancer care in Switzerland Cancer epidemiology
Showing records 1 - 20 (of 61)


MCSS v5.8 PRO. 0.017 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
23/04/2024